Homogeneous paths Sample Clauses

Homogeneous paths. The vertical component of the field strength for a homogeneous path is represented in these graphs as a function of distance, for various values of ground conductivity. The distance in kilometres is shown on a logarithmic scale on the abscissa. The field strength is shown on a linear scale on the ordinate in decibels above 1 μV/m. Graphs 1 to 19 are standardized for a characteristic field strength of 100 mV/m corresponding to an effective monopole radiated power (e.m.r.p.) of – 9.5 dB relative to 1 kW. The straight line marked “100 mV/m at 1 km” is the field strength on the assumption that the antenna is erected on a surface of perfect conductivity. For omnidirectional antenna systems having a different characteristic field strength, correction must be made according to the following equations:
Sample 1
AutoNDA by SimpleDocs
Homogeneous paths. The vertical component of the field strength for a homogeneous path is represented in Figure 2.1 as a function of distance, for various values of ground conductivity. The distance in kilometers is shown on a logarithmic scale on the abscissa. The field strength is shown on a linear scale on the ordinate in decibels above 1 µV/m. The graph is standardized for a characteristic field strength of 100 mV/m corresponding to an effective monopole radiated power (e.m.r.p.) of -9.5 dB relative to 1 kW. The straight line marked "100 mV/m at 1 km" is the field strength on the assumption that the antenna is erected on a surface of perfect conductivity. For omnidirectional antenna systems having a different characteristic field strength, correction must be made according to either of the following equations:
Sample 1

Related to Homogeneous paths

  • Diagnostic Assessment 6.3.1 Boards shall provide a list of pre-approved assessment tools consistent with their Board improvement plan for student achievement and which is compliant with Ministry of Education PPM (PPM 155: Diagnostic Assessment in Support of Student Learning, date of issue January 7, 2013).

  • Geological and Archeological Specimens If, during the execution of the Work, the Contractor, any Subcontractor, or any servant, employee, or agent of either should uncover any valuable material or materials, such as, but not limited to, treasure trove, geological specimens, archival material, archeological specimens, or ore, the Contractor acknowledges that title to the foregoing is vested in the Owner. The Contractor shall notify the Owner upon the discovery of any of the foregoing, shall take reasonable steps to safeguard it, and seek further instruction from the Design Professional. Any additional cost incurred by the Contractor shall be addressed under the provision for changed conditions. The Contractor agrees that the Geological and Water Resources Division and the Historic Preservation Division of the Georgia Department of Natural Resources may inspect the Work at reasonable times.

  • SHOP DRAWINGS, PRODUCT DATA AND SAMPLES 4.12.1 Shop Drawings are drawings, diagrams, schedules and other, data specially prepared for the Work by the Contractor or any Subcontractor, manufacturer, supplier or distributor to illustrate some portion of the Work.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Test Samples The Contractor is responsible for providing Samples of sufficient size for test purposes and for coordinating such tests with the Work Progress Schedule to avoid delay.

  • Dangerous Goods, Special Wastes, Pesticides and Harmful Substances Where employees are required to work with or are exposed to any dangerous good, special waste, pesticide or harmful substance, the Employer shall ensure that the employees are adequately trained in the identification, safe handling, use, storage, and/or disposal of same.

  • Quality Improvement VRC shall develop programs designed to improve the quality of care provided by the Radiologists and encourage identification and adoption of best demonstrated processes. Practice and VRC acknowledge that, in connection with such quality improvement activities, it may be necessary to provide VRC with Protected Health Information and Practice and VRC agree to treat such information in accordance with Article 9;

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Spontaneous assistance The Parties shall assist each other, at their own initiative and in accordance with their legal or regulatory provisions, if they consider that to be necessary for the correct application of customs legislation, particularly by providing information obtained pertaining to:

Time is Money Join Law Insider Premium to draft better contracts faster.